Key facts
- Medsender’s last known valuation is $25.0M (Jan 2025).
- It has raised $7.5M across 1 recorded rounds; the latest was Early Stage VC ($7.5M) in Jan 2025.
- Notable investors include 450 Ventures, Ballast Point Ventures, Mentors Fund.
- Medsender has filed 1 Form D with the SEC, most recently Jan 2025 ($7.5M sold to 31 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Medsender
Funding rounds
1 roundsAbout Medsender
Developer of a workflow automation platform designed for medical practices. The company's platform uses artificial intelligence to extract, structure, and sync data from unstructured sources such as faxes into patient charts that eliminate manual tasks, enabling doctors and staff of health organizations to send and receive health records digitally.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2015
- Employees
- 27
- Website
- medsender.com/
- Ownership
- Privately Held (backing)
Medsender doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medsender shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medsender in its N-PORT filings yet. We sweep new filings monthly.